8/2/19 16:44 | 8/1/19 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | King Gary A. | UT | O | EVP Inte | S.d | -2,609 | 43.49 | 0 | -60 | -31 | 135 | D | | | | | | | | | | | | | | |
8/2/19 16:44 | 8/1/19 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | King Gary A. | UT | O | EVP Inte | M.d | 1,424 | 23.73 | 0 | 60 | 80 | 135 | D | | | | | | | | | | | | | | |
1/22/18 18:16 | 1/22/18 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | King Gary A. | UT | O | EVP Inte | S.d | -1,367 | 39.67 | 0 | -34 | -22 | 122 | D | | | | | | | | | | | | | | |
1/22/18 18:16 | 1/22/18 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | King Gary A. | UT | O | EVP Inte | M.d | 664 | 19.28 | 0 | 34 | 39 | 122 | D | | | | | | | | | | | | | | |
1/19/18 14:21 | 1/18/18 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | King Gary A. | UT | O | EVP Inte | S.d | -119 | 38.12 | 0 | -3 | -2 | 122 | D | | | | | | | | | | | | | | |
1/19/18 14:21 | 1/18/18 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | King Gary A. | UT | O | EVP Inte | M.d | 46 | 14.88 | 0 | 3 | 3 | 122 | D | | | | | | | | | | | | | | |
4/8/16 18:27 | 4/6/16 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | King Gary A. | UT | O | EVP Inte | S.d | -585 | 39.03 | 28 | -15 | -16 | 81 | D | -4 | 8 | 1 | -7 | 11 | 6 | 5 | 3 | 0 | 1 | -11 | -19 | -44 | -51 |
4/8/16 18:27 | 4/6/16 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | King Gary A. | UT | O | EVP Inte | M.d | 270 | 18.00 | 28 | 15 | 23 | 81 | D | -4 | 8 | 1 | -7 | 11 | 6 | 5 | 3 | 0 | 1 | -11 | -19 | -44 | -51 |
4/5/16 10:24 | 4/1/16 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | King Gary A. | UT | O | EVP Inte | S.d | -572 | 38.12 | 29 | -15 | -16 | 81 | D | -3 | 9 | 2 | -12 | 9 | 3 | 5 | 2 | -1 | 1 | -5 | -19 | -46 | -50 |
4/5/16 10:24 | 4/1/16 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | King Gary A. | UT | O | EVP Inte | M.d | 223 | 14.88 | 29 | 15 | 23 | 81 | D | -3 | 9 | 2 | -12 | 9 | 3 | 5 | 2 | -1 | 1 | -5 | -19 | -46 | -50 |
10/28/15 18:34 | 10/28/15 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | King Gary A. | UT | O | EVP Inte | S.d | -428 | 42.82 | 33 | -10 | -11 | 81 | D | 65 | 13 | 25 | 25 | 1 | 4 | 6 | 1 | -4 | -1 | 2 | -11 | -14 | -56 |
10/28/15 18:34 | 10/28/15 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | King Gary A. | UT | O | EVP Inte | M.d | 240 | 23.98 | 33 | 10 | 14 | 81 | D | 65 | 13 | 25 | 25 | 1 | 4 | 6 | 1 | -4 | -1 | 2 | -11 | -14 | -56 |
9/16/15 16:34 | 9/14/15 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | King Gary A. | UT | O | EVP Inte | S.d | -574 | 39.41 | 33 | -15 | -22 | 51 | D | 56 | 12 | 12 | 26 | 24 | 24 | 7 | 6 | 0 | -5 | -7 | 3 | -12 | -48 |
9/16/15 16:34 | 9/14/15 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | King Gary A. | UT | O | EVP Inte | M.d | 284 | 19.47 | 33 | 15 | 39 | 51 | D | 56 | 12 | 12 | 26 | 24 | 24 | 7 | 6 | 0 | -5 | -7 | 3 | -12 | -48 |
9/8/15 16:08 | 9/3/15 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | King Gary A. | UT | O | EVP Inte | S.d | -1,003 | 39.41 | 32 | -25 | -33 | 51 | D | 38 | 6 | 10 | 16 | 16 | 12 | 12 | 5 | -1 | 1 | 1 | 11 | -3 | -47 |
9/8/15 16:08 | 9/3/15 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | King Gary A. | UT | O | EVP Inte | M.d | 495 | 19.47 | 32 | 25 | 98 | 51 | D | 38 | 6 | 10 | 16 | 16 | 12 | 12 | 5 | -1 | 1 | 1 | 11 | -3 | -47 |
9/2/15 16:24 | 9/2/15 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | King Gary A. | UT | O | EVP Inte | S.d | -573 | 38.23 | 30 | -15 | -23 | 51 | D | 40 | 3 | 7 | 6 | 4 | 10 | 10 | 3 | -2 | -1 | -4 | 12 | -7 | -50 |
9/2/15 16:24 | 9/2/15 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | King Gary A. | UT | O | EVP Inte | M.d | 270 | 18.00 | 30 | 15 | 41 | 51 | D | 40 | 3 | 7 | 6 | 4 | 10 | 10 | 3 | -2 | -1 | -4 | 12 | -7 | -50 |
8/31/15 16:14 | 8/28/15 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | King Gary A. | UT | O | EVP Inte | S.d | -1,072 | 35.73 | 25 | -30 | -37 | 51 | D | 38 | 1 | 9 | 11 | 5 | 15 | 7 | 10 | -2 | 2 | -2 | 18 | -6 | -46 |
8/31/15 16:14 | 8/28/15 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | King Gary A. | UT | O | EVP Inte | M.d | 446 | 14.88 | 25 | 30 | 140 | 51 | D | 38 | 1 | 9 | 11 | 5 | 15 | 7 | 10 | -2 | 2 | -2 | 18 | -6 | -46 |
11/5/14 16:08 | 11/3/14 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | King Gary A. | UT | O | EVP Inte | S.d | -262 | 39.95 | 29 | -7 | -11 | 51 | D | 37 | 45 | 0 | 0 | -4 | -4 | 0 | -3 | 1 | -6 | 0 | -1 | -5 | 31 |
11/5/14 16:08 | 11/3/14 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | King Gary A. | UT | O | EVP Inte | M.d | 128 | 19.47 | 29 | 7 | 15 | 51 | D | 37 | 45 | 0 | 0 | -4 | -4 | 0 | -3 | 1 | -6 | 0 | -1 | -5 | 31 |
2/24/14 17:59 | 2/24/14 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | King Gary A. | UT | O | EVP Inte | S.d | -760 | 38.00 | 33 | -20 | -87 | 3 | D | 57 | 50 | 36 | 35 | 67 | 35 | 21 | 7 | -1 | -5 | -12 | -13 | -2 | -8 |
2/24/14 17:59 | 2/24/14 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | King Gary A. | UT | O | EVP Inte | M.d | 360 | 18.00 | 33 | 20 | | 3 | D | 57 | 50 | 36 | 35 | 67 | 35 | 21 | 7 | -1 | -5 | -12 | -13 | -2 | -8 |
2/20/14 17:24 | 2/18/14 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | King Gary A. | UT | O | EVP Inte | M.d | 372 | 14.88 | 33 | 25 | | 3 | D | 47 | 40 | 27 | 30 | 64 | 25 | 7 | 12 | 3 | 3 | 1 | 1 | 3 | -7 |
2/20/14 17:24 | 2/18/14 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | King Gary A. | UT | O | EVP Inte | S.d | -869 | 34.74 | 33 | -25 | -89 | 3 | D | 47 | 40 | 27 | 30 | 64 | 25 | 7 | 12 | 3 | 3 | 1 | 1 | 3 | -7 |